
UK Tobacco Giant BAT Makes Third Cannabis Investment As It Moves Beyond Nicotine
UK tobacco giant BAT has followed up its £127m investment into Organigram with further investment in a Canadian cannabis company. Research-based Trait

UK tobacco giant BAT has followed up its £127m investment into Organigram with further investment in a Canadian cannabis company. Research-based Trait

KANABO’s proposed share-based purchase of high-profile medical cannabis business Materia Ventures is the ‘perfect match’, says Avihu Tamir, its founder

CANNOVUM AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin) has entered into a long term supply agreement with Aurora through its

GERMANY has its first publicly-listed cannabis company in Cannovum, a Berlin-based importer wholesaler and distributor of medical cannabis. Co-founder Pia

CANNABIS investment company Greencare Capital has appointed Richard Tonthat as CEO just weeks after his work with British American Tobacco

ENGLAND World Cup winning cricketer Jason Roy is the latest high-profile sporting star to invest in the CBD space taking

GREEK medical cannabis company Hellenic Dynamics is set to list on the London Stock Exchange as investment appetite for the

A VETRAN of American investment bank JP Morgan has entered the burgeoning field of cannabis with appointments to two UK-based

SCOTTISH CBD firm Voyager Life has announced plans to float on the market after successfully raising over £2m in the

UK investment fund Fast Forward Innovations has added Alfredo Pascual – one of Europe’s leading cannabis industry figures – to

WITH a flurry of activity on the exchanges in the last month the question on the lips of many is

SPECULATION EMMAC Life Sciences would be the next to float on the London Stock Exchange has been brought to a

UK cannabis business EMMAC Life Sciences Group has sold its Yooma Wellness business for over $8m with the emerging Chinese

CANNABIS shares will be traded for the first time in the 320-year history of the London Stock Exchange today –

IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn. The deal will be

THIS time last year cannabis businesses were in the doldrums so the picture currently being viewed would have seemed a

NEWLY-LAUNCHED legal medicinal cannabis fund Verdite Capital plans to make its first investments in the spring of 2021 – with

ONE of the UK’s first cannabis investment funds is being backed by two of the industry’s global leaders as it